Actual Medicinal Product (AMP) Perindopril erbumine 8mg tablets (Alliance Healthcare (Distribution) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight container. Protect from heat. Manufacturer recommends storing in original container. No stability data available in MCAs available.
- Provenance
-
This recommendation is based on the product Perindopril erbumine 8mg tablets (Sandoz Limited).
- Generic
- Perindopril erbumine
- Formulation
- Perindopril erbumine 8mg tablets
-
Perindopril erbumine
-
Perindopril erbumine 8mg tablets
-
Perindopril erbumine 8mg tablets (Alliance Healthcare (Distribution) Ltd)
-
-